A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
26 Sep 2026 · 00:48 CST Terminal Access 终端入口 →
600062.SH上海证券交易所 · 主板 Main

China Resources Double-Crane Pharmaceutical 华润双鹤

Chemical Pharmaceuticals 化学制药
¥16.05+¥0.02 · +0.12%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥16.02
High 最高
¥16.11
Low 最低
¥15.94
Prev Close 昨收
¥16.03
Volume 成交量
503.6万股
Turnover 成交额
¥8,067.8万
Mkt Cap 总市值
¥167亿
P/E 市盈率
10.3×
Recent Activity 近期动态All Filings 全部公告 →

10 significant filings since 29 May 2026: 3 on acquisition or disposal, 3 on buyback and 2 on dividend, and 1 other kind. The latest, on 29 Aug 2026: 华润双鹤关于重大资产重组的进展公告.
自 29 May 2026 起有 10 份重大公告:acquisition or disposal 3 份、buyback 3 份、dividend 2 份,另有 1 类。最新一份(29 Aug 2026):华润双鹤关于重大资产重组的进展公告。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥19.26 · Low 最低 ¥15.25
16.0017.0018.0019.00
Volume 成交量
2,951.4万
Sep 25Dec 25Mar 26Jun 26Sep 26

Against Its Own History 与自身历史比较

10.3×
Median 中值 12.3× · Range 区间 10.3× to 24.6× · 20 periods 期
1.36×
Median 中值 1.75× · Range 区间 1.24× to 2.71× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥16.04¥1.5610.3×¥11.791.36×
31 Mar 2026 一季报¥18.57¥1.5711.8×¥11.671.59×
31 Dec 2025 年报¥18.29¥1.5911.5×¥11.201.63×
30 Sep 2025 三季报¥18.68¥1.5312.2×¥10.901.71×
30 Jun 2025 中报¥18.66¥1.5212.3×¥10.631.76×
31 Mar 2025 一季报¥18.90¥1.5712.0×¥10.511.80×
31 Dec 2024 年报¥19.80¥1.5812.5×¥10.021.98×
30 Sep 2024 三季报¥23.82¥1.6414.5×¥9.812.43×
30 Jun 2024 中报¥19.58¥1.6911.6×¥9.562.05×
31 Mar 2024 一季报¥20.67¥1.7711.7×¥11.081.87×
31 Dec 2023 年报¥18.60¥1.6311.4×¥10.671.74×
30 Sep 2023 三季报¥17.46¥1.5311.4×¥10.431.67×
30 Jun 2023 中报¥17.42¥1.3812.6×¥10.101.73×
31 Mar 2023 一季报¥17.24¥1.1914.5×¥9.981.73×
31 Dec 2022 年报¥17.89¥1.1415.7×¥9.611.86×
30 Sep 2022 三季报¥17.59¥1.0017.6×¥9.411.87×
30 Jun 2022 中报¥25.66¥1.0424.6×¥9.482.71×
31 Mar 2022 一季报¥17.00¥0.9418.1×¥9.541.78×
31 Dec 2021 年报¥13.37¥0.9014.9×¥9.491.41×
30 Sep 2021 三季报¥11.71¥0.9812.0×¥9.461.24×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA